KU Leuven, IKS, 3000, Leuven, Belgium.
JRC, Karlsruhe, Germany.
Sci Rep. 2023 Jan 24;13(1):1347. doi: 10.1038/s41598-023-28299-4.
[Formula: see text]Ac is a radio-isotope that can be linked to biological vector molecules to treat certain distributed cancers using targeted alpha therapy. However, developing [Formula: see text]Ac-labelled radiopharmaceuticals remains a challenge due to the supply shortage of pure [Formula: see text]Ac itself. Several techniques to obtain pure [Formula: see text]Ac are being investigated, amongst which is the high-energy proton spallation of thorium or uranium combined with resonant laser ionization and mass separation. As a proof-of-principle, we perform off-line resonant ionization mass spectrometry on two samples of [Formula: see text]Ac, each with a known activity, in different chemical environments. We report overall operational collection efficiencies of 10.1(2)% and 9.9(8)% for the cases in which the [Formula: see text]Ac was deposited on a rhenium surface and a ThO[Formula: see text] mimic target matrix respectively. The bottleneck of the technique was the laser ionization efficiency, which was deduced to be 15.1(6)%.
[公式:见正文]Ac 是一种放射性同位素,可以与生物载体分子结合,利用靶向 α 治疗来治疗某些转移性癌症。然而,由于纯 [公式:见正文]Ac 本身的供应短缺,开发 [公式:见正文]Ac 标记的放射性药物仍然是一个挑战。正在研究几种获得纯 [公式:见正文]Ac 的技术,其中包括钍或铀的高能质子散裂与共振激光电离和质量分离相结合。作为原理验证,我们在两种不同化学环境下的已知活性的 [公式:见正文]Ac 样品上进行离线共振电离质谱分析。我们报告了在 [公式:见正文]Ac 沉积在铼表面和 ThO[公式:见正文]模拟靶基质的情况下,总收集效率分别为 10.1(2)%和 9.9(8)%。该技术的瓶颈是激光电离效率,推断其为 15.1(6)%。